重组人脑利钠肽治疗急性心肌梗死合并心功能衰竭的应用效果

Application of recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction complicated with heart failure

目的:探讨重组人脑利钠肽治疗急性心肌梗死合并心功能衰竭的应用价值。方法:66例急性心肌梗死合并心功能衰竭患者随机分为对照组和观察组,对照组接受常规治疗,观察组在对照组的基础上加用重组人脑利钠肽治疗,比较两组的治疗效果。结果:治疗后,观察指标均有改善,观察组改善比对照组明显,观察组总有效率90.9%,高于对照组69.7%,差异有统计学意义(P<0.05)。结论:重组人脑利钠肽对急性心肌梗死合并心功能衰竭的治疗效果明显,能有效恢复患者心脏功能。

Objective： To study the effect of recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction combined with heart failure. Methods： 66 patients with acute myocardial infarction complicated with heart failure were randomly divided into the control group and the observation group. The control group received routine treatment. The observation group was treated with recombinant human brain natriuretic peptide on the basis of the control group. Results： After treatment,the observation indexes were improved,the indexes in the observation group were improved significantly than those in the control group. The total effective rate of the observation group was 90. 9%,higher than 69. 7% of the control group,the difference was statistically significant（ P〈0. 05）. Conclusion： Recombinant human brain natriuretic peptide is effective in the treatment of acute myocardial infarction complicated with heart failure and can effectively restore the heart function of patients.